A XM não fornece serviços a residentes nos Estados Unidos da América.

Google-backed software developer GitLab explores sale, sources say



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EXCLUSIVE-Google-backed software developer GitLab explores sale, sources say</title></head><body>

Datadog among interested parties in potential GitLab acquisition

GitLab shares rose as much as 11.5%, up 7% midday

CEO Sid Sijbrandij undergoing cancer treatment, continues duties

GitLab faces pricing headwinds competing with Microsoft GitHub

Adds share price reaction in paragraph 4, analyst comment in paragraph 6

By Milana Vinn and Anirban Sen

NEW YORK, July 17 (Reuters) -GitLab GTLB.O, a U.S. provider of cloud-based software development tools whose investors include Google parent Alphabet GOOGL.O, is exploring a sale after attracting acquisition interest, according to people familiar with the matter.

GitLab, which has a market value of about $8 billion, is working with investment bankers on a sale process that has attracted interest from peers, including cloud monitoring firm Datadog DDOG.O, the sources said.

Any deal is still weeks away and no agreement is certain, the sources said, requesting anonymity because the matter is confidential.

GitLab's shares rose as much as 11.5% before paring gains to 7% in midday trading.

GitLab and Datadog did not respond to requests for comment. Alphabet, which has a 22.2% voting stake in GitLab through its venture capital arm, also did not respond to a request for comment.

"GitLab has long been viewed as an attractive acquisition candidate, in our view. While we sense that investors view AWS or Google Cloud as more obvious buyout candidates, we are positive on a potential tie-up between GitLab and Datadog," Needham analyst Mike Cikos wrote in a note on Wednesday.

Dealmaking in the technology sector is picking up, as advances in artificial intelligence and cloud computing push companies to expand their offerings. Alphabet is in advanced talks to acquire cybersecurity startup Wiz for roughly $23 billion after previously exploring an acquisition offer for marketing software company HubSpot HUBS.N, Reuters has reported.

The technology sector accounted for the largest share of mergers and acquisitions during the first half of 2024, jumping more than 42% year-on-year to $327.2 billion globally, according to data from Dealogic.

GitLab's platform allows development, operations and security teams to design and manage software using a single tool. It has more than 30 million registered users and is deployed by more than half of the Fortune 100 companies, according to its website. Its nominal headquarters are in San Francisco but all its employees work remotely.

GitLab's shares, which have been trading in New York since their initial public offering in 2021, are down 16% so far this year, underperforming a 3% rise in the S&P 500 Application Software index, on concerns about its customers cutting spending.

While the company reported robust year-on-year revenue growth of 33% to $169.2 million and posted its first ever positive cash flow in its latest quarter, it acknowledged it faces headwinds in pricing its offerings as it competes with Microsoft MSFT.O following its $7.5 billion acquisition in 2018 of rival GitHub.

GitLab CEO and co-founder Sid Sijbrandij, who controls 45.51% of the voting stock through dual-class shares, said on the company's quarterly earnings call last month that he would undergo treatment for osteosarcoma, a form of cancer, for a second time after he was also treated for it last year. He added that he is working on making a full recovery and would continue with his duties.

Datadog, which has a market value of $44 billion, offers software that allows technology workers to collaborate and measure their productivity using the cloud.



Reporting by Milana Vinn and Anirban Sen in New York; Editing by Christopher Cushing and Lisa Shumaker

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.